16:21 EDT Zentalis (ZNTL) files $250M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZNTL:
- Zentalis Highlights Promising Azenosertib Data at SGO 2025
- Positive Buy Rating for Zentalis Pharmaceuticals Driven by Promising Efficacy and Safety of Azenosertib in PROC Treatment
- Zentalis presents updated clinical data on azenosertib as SGO 2025
- ZNTL Upcoming Earnings Report: What to Expect?
- Zentalis price target lowered to $6 from $8 at Guggenheim
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue